GlassScriptPhysician profile
Timothy Douglas Mcgarity
NPI 1780614560
$3,953.26
in general payments reported to CMS, 2019-2025
17 companies · $612 in 2025
The $612 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2020: $420 · 2021: $704 · 2022: $844 · 2023: $562 · 2024: $288 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,429 · Honoraria: $32.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,429.23 |
| Honoraria | $32.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,070.81 | 2019-2025 | Tecnis Iol, Tecnis Iol |
| Ivantis, INC | $593.36 | 2019-2021 | |
| Alcon Vision LLC | $590.85 | 2019-2025 | Clareon, Clareon Panoptix Pro |
| Rxsight INC | $583.68 | 2022-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Injector Handpiece |
| Allergan, INC. | $264.12 | 2019-2022 | |
| Glaukos Corporation | $182.11 | 2020-2022 | |
| New World Medical,INC. | $141.79 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $115.51 | 2025 | Xiidra, Miebo |
| Kala Pharmaceuticals, INC. | $104.41 | 2020-2022 | |
| Oyster Point Pharma, INC. | $82.65 | 2023 | Tyrvaya |
| Abbvie INC. | $79.52 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $48.82 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $27.70 | 2025 | Xdemvy |
| Omeros Corporation | $19.02 | 2019 | |
| Harrow Eye, LLC | $18.59 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $16.53 | 2023 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Alcon Research LLC | $13.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Mcgarity listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.